J8670 Rolapitant - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Rolapitant

Brand Name:

Varubi

Strength:

1 mg

HCPCS:

J8670

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Antiemetic

Minor Drug Class:

Substance P/Neurokinin 1

Oral (Y/N):

Yes

FDA Approval Year:

2015

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2017

CMS Discontinuation Date:

Status:

In Use